Abstract
Acute portomesenteric vein thrombosis is potentially lethal. In the present paper, a cirrhotic patient with a previous history of esophageal variceal bleeding presented with acute occlusive portomesenteric vein thrombosis, but achieved complete recanalization by low-molecular-weight heparin followed by rivaroxaban. Notably, no bleeding episode occurred during anticoagulation therapy. This case supported early initiation of anticoagulation in such patients.
Keywords:
Anticoagulation; Bleeding; Liver cirrhosis; Portal vein thrombosis.
Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Acute Disease
-
Esophageal and Gastric Varices / diagnosis
-
Esophageal and Gastric Varices / etiology
-
Esophageal and Gastric Varices / therapy*
-
Factor Xa Inhibitors / therapeutic use*
-
Gastrointestinal Hemorrhage / diagnosis
-
Gastrointestinal Hemorrhage / etiology
-
Gastrointestinal Hemorrhage / therapy*
-
Hemostasis, Endoscopic* / adverse effects
-
Heparin, Low-Molecular-Weight / therapeutic use*
-
Humans
-
Liver Cirrhosis, Alcoholic / complications*
-
Liver Cirrhosis, Alcoholic / diagnosis
-
Male
-
Mesenteric Veins* / diagnostic imaging
-
Middle Aged
-
Portal Vein* / diagnostic imaging
-
Rivaroxaban / therapeutic use*
-
Treatment Outcome
-
Venous Thrombosis / diagnostic imaging
-
Venous Thrombosis / drug therapy*
-
Venous Thrombosis / etiology
Substances
-
Factor Xa Inhibitors
-
Heparin, Low-Molecular-Weight
-
Rivaroxaban